Skip to main content

Table 9 Allergenicity, antigenicity, and physicochemical properties of the final structure of the vaccine

From: Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinology

characteristics

findings

remarks

Number of amino acids

501

suitable

molecular weight

54,059.97 Da

average

Theoretical pI

9.41

basic

chemical formula

C2455H3814N662O694S11

–-

extinction coefficient (at 280 nm in H2O)

77,810 M−1 cm−1

 

estimated half-life (mammalian reticulocytes, in vitro)

30 h

satisfactory

estimated half-life (yeast cells, in vivo)

 > 20 h

satisfactory

estimated half-life (E. coli, in vivo)

 > 10 h

satisfactory

instability index of vaccine

34.63

Stable

aliphatic index of vaccine

72.95

thermostable

grand average of hydropathicity (GRAVY)

-0.317

hydrophilic

antigenicity

0.6455 (VaxiJen v2.0)

0.897722 (ANTIGENPro)

antigenic

allergenicity

No (AllergenFP v1.0)

No (AlgPred)

No (AllerTop v2.0)

non-allergen

solubility

0.766196 (SolPro)

0.504 (Protein-Sol)

soluble

TM helices

No

suitable